Bacteria In Urinary Infections Make Burglar's Tools

Main Category: Urology / Nephrology
Also Included In: Infectious Diseases / Bacteria / Viruses
Article Date: 21 Feb 2009 - 1:00 PDT

email to a friend   printer friendly   opinions  

Bacteria that cause urinary tract infections (UTIs) make more tools for stealing from their host than friendly versions of the same bacteria found in the gut, researchers at Washington University School of Medicine in St. Louis and the University of Washington have found.

The tools, compounds called siderophores, allow the bad bacteria to steal iron from their hosts, making it easier for the bacteria to survive and reproduce. But they also provide a potential way to target the bad strains of bacteria for eradication without adversely affecting the good strains, researchers report in a study published online Feb. 20 by PLoS Pathogens.

"When we treat an infection with antibiotics, it's like dropping a bomb nearly everything gets wiped out, regardless of whether it's helpful or harmful," says lead author Jeff Henderson, M.D., Ph.D., a Washington University infectious disease specialist who treats patients with UTIs at Barnes-Jewish Hospital. "We'd like to find ways to target the bad bacteria and leave the good bacteria alone, and these siderophores are a great lead in that direction."

UTIs are one of the most common infections, causing around $1.6 billion in medical expenses every year in the United States. Half of all women will experience a UTI at some point in their lives, and recurrent UTIs affect 20 to 40 percent of these patients. Scientists believe 90 percent of all UTIs are caused by the bacterium Escherichia coli (E. coli).

The E. coli that cause UTIs may come from the human gut, where several strains of the bacteria reside. Scientists think some of those strains help their human hosts by aiding digestion and blocking other infectious organisms. To study how friendly and infection-causing E. coli strains differ, Henderson and colleagues at the Center for Women's Infectious Disease Research at Washington University used a new approach called metabolomics. Instead of examining genes, metabolomics analyzes all the chemicals produced by a cell, which includes bacterial growth signals, toxins and waste products.

"This allows us to look at the end products of many genes working together," says senior author Scott Hultgren, Ph.D., the Helen L. Stoever Professor of Molecular Microbiology. "We assess what all the various assembly lines are producing and which products disease-causing bacteria prefer to make, such as certain siderophores."

Bacteria studied in the experiment came from recurrent UTI patients treated at the University of Washington. Researchers cultured both E. coli from stool samples and urine samples. They found that the strains from urine made more yersiniabactin and salmochelin, two siderophores that help bacteria scavenge iron to support their own survival.

Iron is an important nutrient typically kept under tight control by the host, and there's evidence that a back-and-forth contest centered on iron has been raging for millennia between disease-causing microbes and the hosts they exploit. For example, studies suggest that humans may make a protein that specifically blocks particular bacterial siderophores.

There may be multiple ways to take advantage of the infectious bacterial strains' reliance on siderophores. Researchers will try to block or disrupt the activity of the proteins that make siderophores, but they also may use what Henderson calls a "Trojan horse" strategy.

"To steal iron, siderophores have to be sent out from the cell, bind to the iron, and then be taken back into the cell," he explains. "If we can design an antibiotic that looks like a siderophore, we might be able to trick only disease-causing bacteria into taking up the drug while leaving other bacteria alone."

Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, Hooton TM, Hultgren SJ. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathogens 5(2): e1000305. doi:10.1371/journal.ppat.1000305

Funding from the Burroughs Wellcome Fund and the National Institutes of Health supported this research.

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked fourth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Washington University in St. Louis
1 Brookings Dr., Campus Box 1070
St. Louis
MO 63130
United States
http:// www.wustl.edu

• Additional
• References
• Citations